8-K: Enhabit Acquired by Kinderhook Industries for $762 Million

Enhabit, Inc. has been acquired by Kinderhook Industries for approximately $762 million, transitioning from a public company to a private entity.

Summary

• Enhabit, Inc. has been acquired by Anchor Parent, LLC (an affiliate of Kinderhook Industries) for $13.80 per share in cash, totaling approximately $762 million.
• The acquisition was completed on May 15, 2026, making Enhabit a wholly owned subsidiary of Anchor Parent, LLC.
• As a result of the transaction, Enhabit's common stock has been delisted from the New York Stock Exchange.
• The company's credit agreement was amended to include an additional $105 million in term loans and a $40 million increase in revolving credit facility commitments.
• All outstanding shares of Enhabit's common stock were cancelled and converted into the right to receive the merger consideration.
• Stock options, restricted stock units (RSUs), and performance stock units (PSUs) were either cashed out, vested, or cancelled based on their terms and the merger agreement.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for Enhabit shareholders who received a cash premium, and for the company's future growth prospects under private equity ownership, though it marks the end of its public trading life.

Positives

• The acquisition provides Enhabit with additional resources and expertise from Kinderhook Industries to drive growth and strengthen clinical capabilities.
• Kinderhook Industries' investment is expected to enable Enhabit to expand access to high-quality care for patients and communities.
• The transaction was completed at a premium of $13.80 per share in cash for Enhabit shareholders.
• The company's credit facility was expanded, providing additional financial flexibility with $105 million in new term loans and a $40 million increase in revolving commitments.

Negatives

• Enhabit's common stock will no longer be publicly traded, meaning shareholders have been cashed out and can no longer participate in future upside.
• The company's reporting obligations under Sections 13 and 15(d) of the Exchange Act will be suspended following the delisting.
• Certain stock options with exercise prices at or above the per-share merger amount were cancelled without any cash payment.

Risks

• Integration risks associated with becoming a private company under new ownership.
• Potential challenges in maintaining Enhabit's patient-centric culture and mission while pursuing growth objectives under private equity ownership.
• The delisting from the NYSE may reduce liquidity and transparency for any future stakeholders if the company were to go public again.

Future Outlook

With Kinderhook's support, Enhabit anticipates benefiting from additional resources and expertise to enable growth, strengthen clinical capabilities, and expand access to high-quality care for patients, families, and the communities it serves.

Management Comments

• "Today marks an exciting milestone for Enhabit as we officially begin our next chapter as a privately held company. With Kinderhooks support, Enhabit will benefit from additional resources and expertise that will enable growth, strengthen our clinical capabilities, and expand access to high-quality care for patients, families and the communities we serve. I want to thank all of Enhabits employees for their dedication and for continuing to stay grounded in our mission and values to deliver extraordinary patient care."
• "Enhabits leadership, patient-centric culture and strong market position align closely with what we look for in a partner, and we are excited to help build on that foundation. We look forward to working together so the Enhabit team can continue expanding access to care, elevating quality, and delivering strong outcomes for patients and families."

Industry Context

StockSavvy.ai notes that this transaction reflects a broader trend of private equity firms acquiring established healthcare service providers, particularly in the home health and hospice sectors, seeking to leverage operational improvements and market expansion opportunities.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Received $13.80 per share in cash, ending their equity participation in Enhabit.
• Employees: Will continue to work under new ownership with a focus on growth and patient care; stock options and RSUs were cashed out or vested.
• Patients and Families: Expected to benefit from expanded access to high-quality home health and hospice care.
• Creditors: The company's credit agreement was amended, indicating ongoing debt obligations with new terms.

Next Steps

• Enhabit will operate as a private company under Kinderhook Industries.
• The company will focus on growth, strengthening clinical capabilities, and expanding access to care.
• NYSE will file a Form 25 to delist and deregister the common stock.
• Enhabit intends to file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act.

Key Dates

Recommendation

The acquisition represents a completed event for public shareholders, who have received their cash consideration. For existing or potential investors in Kinderhook's funds, the focus shifts to the operational execution and growth strategy of Enhabit as a private entity, making a 'hold' appropriate for those already invested in the acquiring entity's strategy, while public shareholders have exited.

Keywords

Enhabit acquisition, Kinderhook Industries, Merger Agreement, Home Health, Hospice Care, Private Equity, Delisting, Form 8-K